BCM
STJ

Blume Capital Management’s St Jude Medical STJ Stock Holding History

Blume Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40
Closed -$3K – 227
2016
Q4 		$3K Hold
40
– – ﹤0.01% 195
2016
Q3 		$3K Sell
40
-40
-50% -$3.23K ﹤0.01% 185
2016
Q2 		$6K Hold
80
– – ﹤0.01% 191
2016
Q1 		$4K Buy
+80
New +$4.36K ﹤0.01% 218

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Blume Capital Management's STJ Position: Q1 2017 in Review

Blume Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 40 shares — an estimated $3K sold.

Blume Capital Management first reported a position in STJ in Q1 2016 and held it in 4 quarters. The position peaked at $6K in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Blume Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Blume Capital Management sold 40 St Jude Medical shares in Q1 2017, an estimated $3K.
  • Blume Capital Management first reported a position in St Jude Medical in Q1 2016 and held it in 4 quarters.
  • Blume Capital Management's St Jude Medical position peaked at $6K in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Blume Capital Management's 13F filing for Q1 2017, filed 12 May 2017.